Clinical profile of patients treated with cefepime/tazobactam: A new ß-lactam/ß-lactamase inhibitor combination
Objectives: Cefepime/tazobactam is a new ß-lactam/ß-lactamase inhibitor combination licensed for clinical use byDrugs Controller General of India. Aim of our study was to analyze the clinical efficacy and safety of cefepime/tazobactamin patients with sepsis. To the best of our knowledge, this is the...
Sparad:
| Huvudupphov: | , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Eldaghayes Publisher
2012-06-01
|
| Serie: | Journal of Microbiology and Infectious Diseases |
| Ämnen: | |
| Länkar: | http://www.jcmid.org/upload/sayi/9/JMID-00583.pdf |
| Taggar: |
Inga taggar, Lägg till första taggen!
|